                </a></li></ul></div><p><strong>Figure 4.  <span>Fate mapping of IEL T cells with the transgenic HY-TCR using RORγt-cre.</span></strong></p><a id="article1.body1.sec2.sec2.fig2.caption1.p1" name="article1.body1.sec2.sec2.fig2.caption1.p1"></a><p>CD4 and CD8α expression by gated HY (T3.70)<sup>+</sup> IEL (left column) is shown in the second column. CD8β expression by gated CD8α<sup>+</sup> cells (second column) is shown in the third column. EYFP expression by HY<sup>+</sup>CD4<sup>−</sup>CD8α<sup>−</sup>, HY<sup>+</sup>CD4<sup>+</sup>, HY<sup>+</sup>CD8αα<sup>+</sup> and HY<sup>+</sup>CD8αβ<sup>+</sup> T cells is shown.</p>
